2019 ReviewYear ended March 2019

Scroll to learn more

Meiji's Business

The Meiji Group provides customers of all ages ―from infants to seniors― with a wide range of products for healthy and fulfilling lives. From delicious confectionaries and wholesome dairy products to body-enhancing nutrition supplements and vital pharmaceuticals, we make people's wellness our main mission.

Meiji's Business

Key Figures

Net Sales
¥1,254.3 billion
1.1%
Operating Income Ratio
7.8 %
0.2 percentage points
Capital Expenditures
¥71.2 billion
Operating Income
¥98.3 billion
3.9%
ROE
12.2 %
0.9 percentage points
R&D Expenses
¥29.1 billion

Breakdown by Segment

Breakdown by Segment

Business Performance Analysis

Food

Net Sales
¥1,056.6 billion
1.6%
Operating Income
¥84.7 billion
0.7%

Income Analysis

Pharmaceuticals

Net Sales
¥198.6 billion
17.9%
Operating Income
¥14.2 billion
29.2%

Income Analysis

Capital Expenditures

Capital Expenditures

Food

¥61.3 billion

Pharmaceuticals

¥9.7 billion

Cash Dividends per Share / Dividend Payout Ratio

Dividend Payout Ratio / Cash Dividends per Share

Future Prospects

It is the second year of our Medium - Term Business Plan, FYE March 2019 through FYE March 2021.
Our consolidated earnings forecast is as follows:

FYE 3/2019
Results
Net sales ¥1,254.3 billion
Operating income ¥98.3 billion
Operating income ratio 7.8%
ROE 12.2%

FYE 3/2020
Targets
¥1,309.0 billion
¥108.0 billion
8.3%
12.3%

(as of May 13, 2019)